{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:41:26Z","timestamp":1780652486252,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.mcp.2022.101815","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:03:41Z","timestamp":1648587821000},"page":"101815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An ELISA-based antigenicity test of rabies recombinant glycoprotein cannot predict its protective potency in vivo"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3363-8361","authenticated-orcid":false,"given":"Dmitriy V.","family":"Volokhov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alethea M.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Furtak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Musiychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Norikane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha B.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Streatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidadi","family":"Yusibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mcp.2022.101815_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.mcp.2022.101815_bib2","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1371\/journal.pntd.0000839","article-title":"Rabies, still neglected after 125 years of vaccination","volume":"4","author":"Bourhy","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mcp.2022.101815_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2018.12.009","article-title":"Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses","volume":"35","author":"Du Pont","year":"2019","journal-title":"Curr. Opin. Virol."},{"issue":"2","key":"10.1016\/j.mcp.2022.101815_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.20506\/rst.37.2.2805","article-title":"Rabies pathogenesis and immunology","volume":"37","author":"Banyard","year":"2018","journal-title":"Rev. Sci. Tech."},{"issue":"2","key":"10.1016\/j.mcp.2022.101815_bib5","first-page":"225","article-title":"Review of human rabies prophylaxis and treatment","volume":"25","author":"Weant","year":"2013","journal-title":"Crit. Care Nurs. Clin."},{"issue":"21","key":"10.1016\/j.mcp.2022.101815_bib6","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2007.02.075","article-title":"Safety review of the purified chick embryo cell rabies vaccine: data from the Vaccine Adverse Event Reporting System (VAERS)","volume":"25","author":"Dobardzic","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.mcp.2022.101815_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004846","article-title":"Post-marketing surveillance of human rabies diploid cell vaccine (Imovax) in the vaccine adverse event reporting system (VAERS) in the United States, 19902015","volume":"10","author":"Moro","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mcp.2022.101815_bib8","first-page":"279","article-title":"Laboratory techniques in rabies: the NIH test for potency","volume":"23","author":"Seligmann","year":"1973","journal-title":"Monogr. Ser. World Health Organ"},{"key":"10.1016\/j.mcp.2022.101815_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biologicals.2019.06.005","article-title":"Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: a NICEATM and IABS workshop report","volume":"60","author":"Poston","year":"2019","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.mcp.2022.101815_bib10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2016.12.039","article-title":"Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - results of an international collaborative study","volume":"35","author":"Morgeaux","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101815_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biologicals.2020.07.010","article-title":"Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities","volume":"68","author":"Akkermans","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.mcp.2022.101815_bib12","first-page":"1","article-title":"A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody","author":"Gairola","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.mcp.2022.101815_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biologicals.2019.05.004","article-title":"Potency test to discriminate between differentially over-inactivated rabies vaccines: agreement between the NIH assay and a G-protein based ELISA","volume":"60","author":"Toinon","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.mcp.2022.101815_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biologicals.2018.06.003","article-title":"Development of a relative potency test using ELISA for human rabies vaccines","volume":"55","author":"Wang","year":"2018","journal-title":"Biologicals"},{"key":"10.1016\/j.mcp.2022.101815_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.mcp.2022.101815_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vaccine.2013.11.026","article-title":"A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use","volume":"32","author":"Abhinay","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.mcp.2022.101815_bib17","doi-asserted-by":"crossref","first-page":"112939","DOI":"10.1016\/j.jim.2020.112939","article-title":"Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein","volume":"492","author":"Soni","year":"2021","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.mcp.2022.101815_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1099\/jgv.0.000998","article-title":"Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses","volume":"99","author":"Evans","year":"2018","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101815_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101815_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/pbi.12428","article-title":"Large-scale production of pharmaceutical proteins in plant cell culture-the Protalix experience","volume":"13","author":"Tekoah","year":"2015","journal-title":"Plant Biotechnol. J"},{"issue":"3","key":"10.1016\/j.mcp.2022.101815_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","article-title":"Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond","volume":"7","author":"Yusibov","year":"2011","journal-title":"Hum. Vaccine"},{"issue":"8","key":"10.1016\/j.mcp.2022.101815_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1586\/14760584.7.8.1173","article-title":"Recent progress in the development of plant derived vaccines","volume":"7","author":"Yusibov","year":"2008","journal-title":"Expert Rev. Vaccines"},{"issue":"2","key":"10.1016\/j.mcp.2022.101815_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pbi.2004.01.015","article-title":"Posttranslational modification of therapeutic proteins in plants","volume":"7","author":"Gomord","year":"2004","journal-title":"Curr. Opin. Plant Biol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101815_bib24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/19420862.2016.1227901","article-title":"Techno-economic analysis of a transient plant-based platform for monoclonal antibody production","volume":"8","author":"Nandi","year":"2016","journal-title":"mAbs"},{"issue":"10","key":"10.1016\/j.mcp.2022.101815_bib25","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.vaccine.2021.01.004","article-title":"Phase III: randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age","volume":"39","author":"Ward","year":"2021","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.mcp.2022.101815_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1105\/tpc.9.6.859","article-title":"Plant viral synergism: the potyviral genome encodes a broad-range pathogenicity enhancer that transactivates replication of heterologous viruses","volume":"9","author":"Pruss","year":"1997","journal-title":"Plant Cell"},{"issue":"6","key":"10.1016\/j.mcp.2022.101815_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1023\/A:1006496308160","article-title":"pGreen: a versatile and flexible binary Ti vector for Agrobacterium-mediated plant transformation","volume":"42","author":"Hellens","year":"2000","journal-title":"Plant Mol. Biol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101815_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1750-2659.2006.00005.x","article-title":"A launch vector for the production of vaccine antigens in plants","volume":"1","author":"Musiychuk","year":"2007","journal-title":"Influenza Respir. Viruses"},{"issue":"Suppl","key":"10.1016\/j.mcp.2022.101815_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/hv.7.0.14561","article-title":"Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza","volume":"7","author":"Shoji","year":"2011","journal-title":"Hum. Vaccine"},{"issue":"1","key":"10.1016\/j.mcp.2022.101815_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2004.11.003","article-title":"Improved ELISA test for determination of potency of inactivated poliovirus vaccine (IPV)","volume":"33","author":"Rezapkin","year":"2005","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.mcp.2022.101815_bib31","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mcp.2022.101815_bib32","first-page":"171","article-title":"Comparison studies on potency tests for rabies vaccines","volume":"40","author":"Wiktor","year":"1978","journal-title":"Dev. Biol. Stand."},{"issue":"3","key":"10.1016\/j.mcp.2022.101815_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ar.1092190302","article-title":"Use of animals in experimental research: a scientist's perspective","volume":"219","author":"Bulger","year":"1987","journal-title":"Anat. Rec."},{"issue":"2","key":"10.1016\/j.mcp.2022.101815_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"issue":"Pt 6","key":"10.1016\/j.mcp.2022.101815_bib35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1099\/0022-1317-83-6-1465","article-title":"Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type","volume":"83","author":"Maillard","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"Pt 7","key":"10.1016\/j.mcp.2022.101815_bib36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1099\/0022-1317-80-7-1647","article-title":"Soluble ectodomain of rabies virus glycoprotein expressed in eukaryotic cells folds in a monomeric conformation that is antigenically distinct from the native state of the complete, membrane-anchored glycoprotein","volume":"80","author":"Gaudin","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"Pt 8","key":"10.1016\/j.mcp.2022.101815_bib37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","article-title":"Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein","volume":"74","author":"van der Heijden","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.mcp.2022.101815_bib38","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/jvi.64.8.3804-3809.1990","article-title":"Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.mcp.2022.101815_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7030110","article-title":"The cellular immune response to rabies vaccination: a systematic review","volume":"7","author":"Overduin","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.mcp.2022.101815_bib40","first-page":"23","article-title":"Potency testing of inactivated rabies vaccines using a serological method","volume":"134","author":"Kamphuis","year":"2012","journal-title":"Dev. Biol."},{"key":"10.1016\/j.mcp.2022.101815_bib41","first-page":"183","article-title":"Use of the antibody assay in immunized mice for the determination of rabies vaccine potency","volume":"40","author":"Fitzgerald","year":"1978","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.mcp.2022.101815_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0092-1157(84)80008-6","article-title":"A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein","volume":"3","author":"Ferguson","year":"1984","journal-title":"J. Biol. Stand."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:16:54Z","timestamp":1760192214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850822000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":42,"alternative-id":["S0890850822000263"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101815","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ELISA-based antigenicity test of rabies recombinant glycoprotein cannot predict its protective potency in vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101815"}}